Aspirin (acetylsalicylic acid, ASA), the most widely used nonsteroidal anti-inflammatory drug (NSAID) has been prescribed for over 100 years, because of its analgesic, antipyretic and antiinflammatory properties (Mojtabavi et al., 2014) .
Aspirin completely inhibited bisoxygenation of arachidonate by prostaglandin endoperoxide PGH synthase-1; in contrast, aspirintreated PGH synthase-2 metabolized arachidonate primarily to 16-hydroxyeicosatetraenoic acid (15-HETE) instead of PGH2. IDao values were determined for a panel of common NSAIDs by measuring instantaneous inhibition of cyclooxygenase activity using an oxygen electrode. Among common NSAIDs tested, indomethacin, sulindac sulfide, and piroxicam preferentially inhibited PGH synthase-1; ibuprofen, flurbiprofen, and meclofenamate inhibited both enzymes with comparable potencies; and 6-methoxy-2-naphthylacetic acid preferentially inhibited PGH synthase-2. These results demonstrate that the two PGH synthases are pharmacologically distinct and indicate that it may be possible to develop isozyme-specific cyclooxygenase inhibitors useful both for antiinflammatory therapy and for delineating between the biological roles of the PGH synthase isozymes (Meade et al., 1993) .
Pain associated with inflammation involves prostaglandins synthesized from arachidonic acid (AA) through cyclooxygenase-2 (COX-2) pathways while thromboxane A (Meade et al., 1993) formed by platelets from AA via cyclooxygenase-1 (COX-1) mediates thrombosis (Rimon et al., 2010) . COX-1 and COX-2 are both targets of nonselective nonsteroidal antiinflammatory drugs (nsNSAIDs) including aspirin whereas COX-2 activity is preferentially blocked by COX-2 inhibitors called coxibs (Meade et al., 1993) . COXs are homodimers composed of identical subunits, but we have shown that only one subunit is active at a time during catalysis; moreover, many nsNSAIDS bind to a single subunit of a COX dimer to inhibit the COX activity of the entire dimer. Smith and et al based on our experimental studies show that thatcelecoxib and other coxibs bind tightly to a subunit of COX-1. Although celecoxib binding to one monomer of COX-1 does not affect the normal catalytic processing of AA by the second, partner subunit, celecoxib does interfere with the inhibition of COX-1 by aspirin in vitro. X-ray crystallographic results obtained with a celecoxib/COX-1 complex show how celecoxib can bind to one of the two available COX sites of the COX-1 dimer. COX-2 inhibitors such as celecoxib are widely used for pain relief. Because coxibs exhibit cardiovascular side effects, they are often prescribed in combination with lowdose aspirin to prevent thrombosis (Rimon et al., 2010) . ASA irreversibly inhibits cyclooxygenase enzyme (COX) or prostaglandin endoperoxide synthase (PGHS) by acetylating a serine residue at position 529 and places a bulky substituent on serine oxygen, which inhibits binding of arachidonic acid (Mojtabavi et al., 2014) .
ASA also has an antiplatelet effect by inhibiting the production of thromboxane, which under normal circumstances binds platelet molecules together to create a patch over damaged walls of blood vessels. Because the platelet patch can become too large and also block blood flow, locally and downstream, ASA is also used longterm, at low doses, to help prevent heart attacks, strokes, and blood clot formation in people at high risk of developing blood clots (Lewis et al., 1983) . It has also been established that low doses of ASA may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue (Krumholz et al., 1995; Julian et al., 1996) . ASA may be effective at preventing certain types of cancer, particularly colorectal cancer (Algra AM, Rothwell, 2010; Rothwell et al., 2012a; Rothwell et al., 2012b) .
The widely used theoretical methods include MD method based on molecular mechanics (Huang et al., 2012 ) quantum mechanical method (Wang et al., 2012) and other high delity computational model based on rst principles (Ellabaan et al., 2012) The method used to study lipid bilayer systems usually is equilibrium MD method using atomistic (Heine et al., 2007) or coarse grain model (Yuan et al., 2009 ) This method depends largely on the simulation time and the initial conguration. The simulation time is limited to tens to hundreds of nanoseconds for most biological system, so equilibrium MD cannot be used to explore portions of the energy landscape separated by high barriers from the initial minimum (Hamelberg and McCammon, 2004) . To overcome this defect of equilibrium MD, a number of approaches have been introduced: replica exchange, umbrella sampling, accelerated MD (aMD), and so on. The identification of two isoforms of COX has led to a reevaluation of the mechanism through which nonsteroidal anti-inflammatory drugs (NSAIDs) cause injury to the gastric mucosa. The observation that selective inhibition of cyclooxygenases II (COX II) spares gastric prostaglandin (PG) synthesis and is associated with a greatly reduced incidence of gastric erosions compared with what is observed with conventional NSAIDs (Masferrer et al., 1994; Chan et al., 1995) .
Cyclooxygenases I (COX I) is built in many different cells to create prostaglandins used for basic housekeeping messages throughout the body. The second enzyme is built only in special cells and is used for signaling pain and inflammation. Unfortunately, ASA attacks both. Since that it is the suppression of gastric COX-1 by NSAIDs that is the key mechanism responsible for erosion formation, so that with COX I is targeted, ASA can lead to unpleasant complications, such as stomach bleeding (Wallace et al., 2000) .
Fortunately, specific compounds that block just COX II, leaving COX I to perform its essential jobs, are now becoming available. These new drugs are selective pain-killers and fever reducers, without the unpleasant side-effects. In this study, we actually build two different COX for different purposes.
METHODS

Data Sets
In this study, we used bioinformatics from the RCSB PDB, Drug Bank databases. Drug Bank is a unique Bioinformatics/ Cheminformatics fountain that adds detailed drug (i.e., chemical) data comprehensive drug target (i.e., protein).
The docking procedure MD simulation is designed for the automated search of every entry of the protein database for potential protein targets of molecule. For comparison, the dynamic model based on the MD simulations is provided we was used to Isomers and derivatives of aspirin on features pharmacophore models; see Figure 1 .
The 3D structures of ligands ( Figure 1 ) were at first built using ArgusLab 4.0.1 molecular builder and then optimized using the GAUSSIAN package 0.3 using B3LYP with 6-31g* basis set (Morris et al., 2009 ). All rotatable bonds were assigned for the ligands, and also partial charges and nonpolar hydrogens were calculated and merged using the above mentioned method for the receptor. The crystal structure of COX I and II was taken from PDB database using PDB ID COX I: 1CQE and ID COX II: 6COX, the missing atoms and loops were cleaned (Cosconati et al., 2010) , and all residues were protonated under pH 7.4 conditions.
Molecular docking
Docking is the process by which two molecules fit together in three-dimensional space and molecular docking is a useful tool in structural molecular biology and computer-assisted drug design and bioinformatics is seen as an emerging field with the potential to significantly improve how drugs are found and brought to the clinical trials and eventually released to the marketplace. This method is widely used to predict the predominant binding mode(s) oligand with a protein. Besides, reliability in docking of ligand molecules to protein or other targets is an important challenge for molecular modeling. One applications of the docking technique includes the prediction of the binding mode of novel drugs. Docking permits the scientist to virtually screen a database of compounds and bode the strongest binders based on variant scoring functions. The docking analyses were carried by Hex (6.1) and AutoDock (4.2) docking software. Hex calculates protein-ligand docking, and it can superpose pairs of molecules using only witting of their 3D shapes. It avails Spherical Polar Fourier (SPF) correlations to accelerate the calculations and its one of the few docking programs which has built in graphics to view the effect. It explores ways in which two molecules, such as compounds ( Figure 1 ) and COX I and II fit together and dock to each other well. The collection of compounds and COX I and II was discovered via docking and their relative stabilities were evaluated using molecular dynamics and their binding affinities, using free energy simulations. The parameters applied for the docking process via Hex . This program is designed to predict how small molecules, such as drug candidates, bind to a receptor. For the ligand conformational searches the Lamarckian genetic algorithm (LGA) was selected. 3D atomic coordinates of COX I and II were obtained from the Protein Data bank (Morris et al., 2009 ) and prepared for docking. All nonpolar hydrogens were merged and partial atomic charges were assigned using the Gasteiger-Marsili method. Different grid boxes with different grid points in size with a grid-point spacing of 0.375 Å were considered for docking. Each map was centered such that it covered the entire protein including all possible binding sites.
All the AutoDock docking runs were performed in Intel (R) Xeon (R) CPU 5150 @ 2.55 GHz, 2.5GB RAM in Apple system. AutoDock was compiled and run under Windows ubuntu 13.01 operating system. Autodock results were analyzed to study the interactions and the binding energy of the docked structure. Docking Analysis.
The generated ligands were docked into the defined binding site on the COX I and II protein structure. Ligplot plus was used to analysis docking poses for H-bond and hydrophobic interactions.
MolecularDynamics Simulation
The molecular dynamic simulation was carried out by GROMACS 4.5.4 package (Pronk et al., 2013) to simulate the dynamic structure of COX I and II with docked compounds. We utilize Gromacs96 force field for the simulation system (Shukla and Leszcynski, 2006) . The distance between the edge of box and protein was set to 1.2 nm. Each protein-ligand system was placed in cubic cell containing water molecular by water model SPC (Simple point charge). Nonbonded interactions include repulsion, dispersion, and Coulomb terms. The repulsion and dispersion terms involve Lennard-Jones interaction (Jones, 1924 ) and Buckingham potential (Buckingham, 1938) ; the cutoff distance of define van der Waals (VDW) residues was set to 1.4 nm. Long-range electrostatic forces were performed using the PME method (Darden et al., 1993; Essmann et al., 1995) . The equation of Lennard-Jones interaction is as follows:
The Buckingham potential is defined as Topology files and parameters of small compounds in protein-ligand complexes were generated for GROMACS simulation by SwissParam web server (Zoete et al., 2011) . Bonds lengths were constrained by the linear constraint solver (LINCS) algorithm. Na+ and Cl" ion were randomly replaced with water molecular to neutralize the simulation systems, and the concentration was set as 0.145M in solvent system. The energy minimization was used to stabilize the solvent system by Steepest Descent algorithm with 5,000 steps, the follow by equilibration performed under position restraints to equilibrated water molecular in the protein for 1 ns under constant temperature dynamics (NVT type) conditions. In final step, production running for 5000 ps under constant pressure and temperature dynamics (NPT type); all of the temperature simulation system was under 310K condition. MD conformations are sampled every 20 ps and all frames are analyzed under GROMACS 4.5.4.
RESULTS AND DISCUSSION
Hex Results
We used the Hex (6.1) score to select potent ASA compounds which have high affinity with COX I and II. The results of the docking score are listed in Table 1 . Prediction of interaction 
AutoDock Results
It was noted that the reaction of ASA with nucleophilic reagents occurs via a direct nucleophilic attack on the phenolic ester carbonyl carbon atom (Scheme 1) instead of via an anhydride intermediate. The same mechanism appears to be straightforward for the ASA-COX reaction as well. Molecular modeling using the SCC-DFTB method in QM/MM dynamics supports this assumption (Toth et al., 2013) . Derivatization of the carboxylate moiety in moderately selective COX-1 inhibitors, such as 5, 8, 11, 14-eicosatetraynoic acid (ETYA) and arylacetic and fenamic acid NSAIDs, exemplified by indomethacin and meclofenamic acid, respectively, generated potent and selective COX-2 inhibitors. In the indomethacin series, esters and primary and secondary amides are superior to tertiary amides as selective inhibitors. Only the amide derivatives of ETYA and meclofenamic acid inhibit COX-2; the esters are either inactive or nonselective. Inhibition kinetics reveal that indomethacin amides behave as slow, tight-binding inhibitors of COX-2 and that selectivity is a function of the time-dependent step. Site-directed mutagenesis of murine COX-2 indicates that the molecular basis for selectivity differs from the parent NSAIDs and from diarylheterocycles (Kalgutkar et al., 2000) . COX I and II, the Macromolecule and the ligands (six compounds) were subjected to docking analysis using Autodock (4.2). Molecular docking simulations were conducted with this software suite. 20 docking runs were performed. Grid parameters were set as mentioned earlier and spacing between grid points was 0.375 Å. After the simulations were complete, the docked structures were analyzed and the interactions were seen. Hydrogen bond interactions and the binding distance between the donors and acceptors were measured for the best conformers. Distinct conformational clusters were formed at an RMSD-tolerance of 2.0 Å. Van der waals scaling factor was found to be 1.0 Å. To predict the appropriate interaction of six compounds with COX I and II, the ligand molecules were docked with the target protein using Autodock. The analysis command in the docking parameter file in this software causes AutoDock to perform a cluster analysis of the different docked conformations and find the minimum energy in each run. Every docking contains some useful knowledge which includes Binding Energy (Eb) which is the sum of the Intermolecular Energy, the Torsional Energy, and the Internal Energy which are reported in table 2 and 3. kI is the dissociation constant for a ligand with this Binding Energy, Cluster RMS is the root mean square difference in coordinates between this conformation and the cluster reference. In all of our cases it was found zero, because the selected conformations are the cluster reference. Reference RMS is the rms difference between this structure and the input structure.
The study and compare of all dockings indicates that ASA, S1 and S2 ligands with the receptor protein, COX I and COX II, gave the best docking results. According to in table 2 and 3.
Scaffold of the top six compounds is shown in Figure 1 , and the docking poses of each ligand are displayed in Figure 2 and 3 .
For H-bond analysis, compounds docked ligand formed with any residue of COX I and COX II that results are shown in Table 2 (Adinarayana et al., 2012) . The efficiency and selectivity properties of ASA are somewhat astonishing because no neighboring groups such as glutamate and histidine are present in the vicinity of Ser529 to increase its nucleophilicity and reactivity. Since, the reaction of other acetylating agents with COX-1 does not lead to acetylation of Ser529, it has been suggested that the cause of this selective acetylation was due to salicylic acid moiety. The only residue with positive charge in the active site is Arg119, which is located 9.7 Å below the hydroxyl group of Ser529. Consequently, this resulted in a well-positioned situation to arrange the binding of salicylic acid moiety near Ser529 (Mojtabavi Naeini et al., 2014) . Loll et al. illustrated that the hydroxyl group of Tyr384 and carbonyl oxygen of the bromoacetyl group in bromoacetylaspirin-COX-1complex were within Hbonding distance. This could suggest stabilizing the negative charge on the putative tetrahedrial intermediate during acetylation process, and therefore, increasing the reactivity of the acetyl group of ASA near the site of Ser529 would increase (Loll et al., 1995) . Experimental sitedirectedmutagenesis of Arg119 and Tyr384 (the reduced potency on R119Q, loss of function on R119A as well as loss of activity on Y384F mutants) suggested a critical role for these two residues (Hochgesang et al., 2000) .
Stability Analysis
Complexes of with docked COX I and II ligands were performed by MD simulation at 5000 ps, and COX I and II with no ligand (COX I & II protein) were regarded as the control for comparison. Each plot of the root mean square deviation (RMSD), mean square displacement (MSD). The COX I & II protein of COX II changed significantly from 4.5 to 7.5 nm after 5000 ps, indicating that COX II with ligand was more stable during MD simulation. The MSD analysis was used to calculate the migration distance among all simulation times. The MSD values for COX II increased from 19 to 100 ps, which displayed a similar movement distance to S3 at final simulation time. S2 had an increased RMSD value with a simulation time of 5000 ps. For total energy analysis significantly increased values were observed among all simulation times (Table 4 and 5).
Hydrogen bonds
As COX I and II have one hydrogen bond donor (OH) and one hydrogen bond acceptor (O), the probability to form hydrogen bonds is rare. Number of H-bonds formed between COX I and II and asprin, S1, S2 and S3 molecules during aMD simulation was calculated. Of all these three cases, the number of H-bonds fluctuates between 0 and 890 ( Figure 6 and 7) .
CONCLUSIONS
The Protein-Ligand interaction plays a main role in structural based drug charting. In the present work we have taken change structure ASA for effective further on COX II for novel drug design. The receptor (COX I and II) was docked with ASA, ASA-S1, ASA-S2, ASA-S3, ASA-S4 and ASA-S5 and the energy values obtained. After MD simulation, the top two isomers of aspirin remain as the same docking poses under dynamic conditions. Hence, we propose the aspirin isomers, as potential candidates for repression COX 2 is to reduce the side effects of aspirin that required to clinical research.
